Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: An analysis from the ACUITY trial

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 2, 2011, Pages 154-164

  Caixeta, Adriano ^b   Stone, Gregg W ^b   Mehran, Roxana ^a   Lee, Edwin A ^b   McLaurin, Brent T ^c   Cox, David A ^d   Bertrand, Michel E ^e   Lincoff, A Michael ^f   Moses, Jeffrey W ^b   White, Harvey D ^g   Ohman, E Magnus ^h   Palmerini, Tullio ⁱ   Syros, George ^j   Kittas, Christos ^k   Fahy, Martin ^b   Hooper, W Craig ^m   Lansky, Alexandra J ^l   Dangas, George D ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c ANMED HEALTH   (United States)

^d Mid Carolina Cardiology   (United States)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f LERNER RESEARCH INSTITUTE   (United States)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j ST ELIZABETH'S MEDICAL CENTER   (United States)

^k UNIVERSITY OF ATHENS   (Greece)

^l YALE UNIVERSITY MEDICAL CENTER   (United States)

^m NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

more..

Author keywords

Acute coronary syndrome; C reactive protein; Invasive strategy; Long term mortality

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CORONARY ARTERY BYPASS GRAFT; EARLY INTERVENTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS;

EID: 79951725644     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0516-y     Document Type: Article

References (25)

1. R Ross 1999 Atherosclerosis-an inflammatory disease N Engl J Med 340 115 126 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
2. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 973 979 1:CAS:528:DyaK2sXisFOrtL0%3D 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
3. F Haverkate SG Thompson SD Pyke JR Gallimore MB Pepys 1997 Production of C-reactive protein and risk of coronary events in stable and unstable angina European Concerted Action on Thrombosis And Disabilities Angina Pectoris Study Group Lancet 349 462 466 1:STN:280:DyaK2s7pt12rtg%3D%3D 10.1016/S0140-6736(96) 07591-5 9040576 (Pubitemid 27077826)
4. B Lindahl H Toss A Siegbahn P Venge L Wallentin 2000 Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease FRISC Study Group. Fragmin during instability in coronary artery disease N Engl J Med 343 1139 1147 1:STN:280: DC%2BD3cvpslCitA%3D%3D 10.1056/NEJM200010193431602 11036119
5. C Heeschen CW Hamm J Bruemmer ML Simoons 2000 Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet therapy in unstable angina REfractory to standard treatment trial J Am Coll Cardiol 35 1535 1542 1:CAS:528:DC%2BD3cXjvVWjsLw%3D 10.1016/S0735-1097(00)00581-7 10807457 (Pubitemid 30307497)
6. DA Morrow N Rifai EM Antman DL Weiner CH McCabe CP Cannon E Braunwald 1998 C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy thrombolysis in myocardial infarction J Am Coll Cardiol 31 1460 1465 1:CAS:528:DyaK1cXktV2nu7o%3D 10.1016/S0735-1097(98)00136-3 9626820 (Pubitemid 28273285)
7. G Liuzzo LM Biasucci JR Gallimore RL Grillo AG Rebuzzi MB Pepys A Maseri 1994 The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 417 424 1:STN:280:DyaK2czgvFKruw%3D%3D 10.1056/NEJM199408183310701 7880233 (Pubitemid 24247397)
8. SK James P Armstrong E Barnathan R Califf B Lindahl A Siegbahn ML Simoons EJ Topol P Venge L Wallentin 2003 Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy J Am Coll Cardiol 41 916 924 1:CAS:528:DC%2BD3sXislejsL8%3D 10.1016/S0735-1097(02)02969-8 12651034 (Pubitemid 36315530)
9. C Mueller HJ Buettner JM Hodgson S Marsch AP Perruchoud H Roskamm FJ Neumann 1042 Inflammation, long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in consecutive patients Circulation 2002 105 1412 1415
10. F Schiele N Meneveau MF Seronde R Chopard V Descotes-Genon J Dutheil JP Bassand 2010 C-reactive protein improves risk prediction in patients with acute coronary syndromes Eur Heart J 31 290 297 1:CAS:528:DC%2BC3cXhslOgt7w%3D 10.1093/eurheartj/ehp273 19578164
11. KM Eggers B Lagerqvist P Venge L Wallentin B Lindahl 2009 Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome J Am Coll Cardiol 54 357 364 10.1016/j.jacc.2009.03.056 19608034
12. PM Ridker E Danielson FA Fonseca J Genest AM Gotto Jr JJ Kastelein W Koenig P Libby AJ Lorenzatti JG Macfadyen, et al. 2009 Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 1175 1182 1:CAS:528:DC%2BD1MXktV2gsL8%3D 10.1016/S0140-6736(09)60447-5 19329177
13. PM Ridker CP Cannon D Morrow N Rifai LM Rose CH McCabe MA Pfeffer E Braunwald 2005 C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 20 28 1:CAS:528:DC%2BD2MXis12msA%3D%3D 10.1056/NEJMoa042378 15635109 (Pubitemid 40075677)
14. DA Morrow JA de Lemos MS Sabatine SD Wiviott MA Blazing A Shui N Rifai RM Califf E Braunwald 2006 Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial Circulation 114 281 288 1:CAS:528:DC%2BD28XntVSms70%3D 10.1161/CIRCULATIONAHA.106.628909 16847150 (Pubitemid 44297094)
15. ER Ferreiros CP Boissonnet R Pizarro PF Merletti G Corrado A Cagide OO Bazzino 1999 Independent prognostic value of elevated C-reactive protein in unstable angina Circulation 100 1958 1963 1:CAS:528:DyaK1MXnvVaqsb8%3D 10556221 (Pubitemid 29529287)
16. LM Biasucci G Liuzzo RL Grillo G Caligiuri AG Rebuzzi A Buffon F Summaria F Ginnetti G Fadda A Maseri 1999 Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability Circulation 99 855 860 1:STN:280:DyaK1M7lt1SltQ%3D%3D 10027805 (Pubitemid 29094296)
17. GW Stone BT McLaurin DA Cox ME Bertrand AM Lincoff JW Moses HD White SJ Pocock JH Ware F Feit, et al. 2006 Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2203 2216 1:CAS:528:DC%2BD28Xht1Chsb3L 10.1056/NEJMoa062437 17124018 (Pubitemid 44791162)
18. JW Eikelboom SR Mehta SS Anand C Xie KA Fox S Yusuf 2006 Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 774 782 10.1161/CIRCULATIONAHA.106.612812 16908769 (Pubitemid 44268228)
19. NS Anavekar JJ McMurray EJ Velazquez SD Solomon L Kober JL Rouleau HD White R Nordlander A Maggioni K Dickstein, et al. 2004 Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 1285 1295 1:CAS:528:DC%2BD2cXnvFSgsb0%3D 10.1056/NEJMoa041365 15385655 (Pubitemid 39258422)
20. H Toss B Lindahl A Siegbahn L Wallentin 1997 Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease FRISC Study Group. Fragmin during instability in coronary artery disease Circulation 96 4204 4210 1:STN:280:DyaK1c%2Fnsleltw%3D%3D 9416883 (Pubitemid 28007445)
21. LM Biasucci 2004 CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper Circulation 110 560 567 10.1161/01.CIR.0000148983.88334.80
22. T Anzai T Yoshikawa H Shiraki Y Asakura M Akaishi H Mitamura S Ogawa 1997 C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction Circulation 96 778 784 1:STN:280:DyaK2svgslOgsQ%3D%3D 9264482 (Pubitemid 27329609)
23. K Ono A Matsumori T Shioi Y Furukawa S Sasayama 1998 Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling Circulation 98 149 156 1:CAS:528:DyaK1cXkvVSqu7c%3D 9679721 (Pubitemid 28317895)
24. M Griselli J Herbert WL Hutchinson KM Taylor M Sohail T Krausz MB Pepys 1999 C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1733 1740 1:CAS:528:DC%2BD3cXitleg 10.1084/jem.190.12.1733 10601349 (Pubitemid 30013840)
25. D Rothenbacher W Koenig H Brenner 2006 Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease Arch Intern Med 166 2455 2460 1:CAS:528:DC%2BD2sXls1yhtg%3D%3D 10.1001/archinte.166.22.2455 17159010 (Pubitemid 44913229)